Supporting this observation, CST has been shown to promote ploy (ADP-ribose) polymerase inhibitor (PARPi) sensitivity in BRCA1-deficient cancer cells (Barazas et al., 2018; Mirman et al., 2018). The gene discussed is BRCA1; the disease is cancer.